Tag Archive | "chemotherapy"

Expert says Nivolumab Poised to Change Standard of Care in SCCHN

Wednesday, August 24, 2016

0 Comments

Source: www.onclive.com Author: Laura Panjwani Nivolumab (Opdivo) is a game-changing agent for the treatment of patients with squamous cell carcinoma of the head and neck (SCCHN), according to Robert L. Ferris, MD, PhD. “Recent findings have shown us that this agent is really the new standard-of-care option for all platinum-refractory patients with head and neck […]

Continue reading...

New study analyzes physical therapy for head and neck cancer survivors

Sunday, June 26, 2016

0 Comments

Source: www.curetoday.com Author: Andrew J. Roth The aftermath of treatment for head and neck cancer can be particularly difficult, according to Ann Marie Flores. Flores, assistant professor, Department of Physical Therapy, Movement & Rehabilitation Science, Bouvé College of Health Sciences, Northeastern University, conducted a pre-pilot study looking at early physical therapy education for this patient […]

Continue reading...

Heading back to the office following head and neck cancer

Sunday, June 5, 2016

0 Comments

Source: blogs.biomedcentral.com Author: Daniel Caley In Cancers of the Head & Neck launching today publishes the first study looking at disability and employment outcomes in patients with head and neck cancer related to the human papillomavirus (HPV). Dr Shrujal Baxi, Section Editor for survivorship and patient related outcomes and author of this study, explains more […]

Continue reading...

Type 2 diabetes drug could be beneficial for head and neck cancer patients

Sunday, June 5, 2016

0 Comments

Source: www.eurekalert.org Author: press release Researchers at the University of Cincinnati (UC) College of Medicine have found that adding increasing doses of an approved Type 2 diabetes drug, metformin, to a chemotherapy and radiation treatment regimen in head and neck cancer patients is not well tolerated if escalated too quickly, but allowing slower escalation could […]

Continue reading...

Checkpoint inhibitors seen to show potential of immunotherapy in several cancer studies

Wednesday, May 4, 2016

0 Comments

Source: immuno-oncologynews.com Author: Magdalena Kegel Several new checkpoint inhibitors — a class of immunotherapy drugs used in cancer — continue to show beneficial effects in numerous cancer types, according to data presented at the recent American Association for Cancer Research Annual Meeting in New Orleans. Investigated checkpoint inhibitors confirmed earlier results showing evidence of efficacy […]

Continue reading...

Drug Target in Rare, Lethal Glandular Cancer Discovered

Thursday, April 21, 2016

0 Comments

Source: www.dddmag.com Author: Yale University   Using a novel cell culture approach, Yale Cancer Center researchers have discovered critical vulnerabilities in adenoid cystic carcinoma (ACC), a rare and lethal glandular cancer with a high recurrence rate and few treatment options. The findings, published April 15th in the journal Clinical Cancer Research, offer data that ACC […]

Continue reading...

Study supports immunotherapy/radiation combo in head and neck cancer

Monday, April 11, 2016

0 Comments

Source: www.onclive.com Author: Laura Panjwani There may be potential synergy between radiation therapy, given with or without chemotherapy, and immune checkpoint inhibitors in patients with squamous cell carcinoma of the head and neck (SCCHN), according to results of a prospective study. The study, which was presented at the the 2016 Multidisciplinary Head and Neck Cancer […]

Continue reading...

Patient survives stage IV, inoperable throat cancer in clinical trial

Monday, March 21, 2016

0 Comments

Source: medicalxpress.com Author: staff It took a white lie to get David Polisini, 79, to a doctor in 2004, after months of being unable to swallow. “Two of my daughters, Toni and Susie, showed up on my back porch and told me to put my jacket on,” he says. “They told me we were just […]

Continue reading...

Depressed Head and Neck Cancer Patients Have Lower Survival and Higher Recurrence Risk

Wednesday, December 30, 2015

0 Comments

Source: www.OncologyNurseAdvisor.com Author: Kathy Boltz, PhD   Depression is a significant predictor of 5-year survival and recurrence in patients with head and neck cancer, according to a new study published in Pyschosomatic Medicine (doi: 10.1097/PSY.0000000000000256). These findings represent one of the largest studies to report on the impact of depression on cancer survival. Although depression […]

Continue reading...

Poison’s Rikki Rockett Reveals He Is Battling Oral Cancer

Tuesday, December 15, 2015

0 Comments

Source: www.loudwire.com Author: Chad Childers   Poison drummer Rikki Rockett revealed during an appearance on the Eddie Trunk Live radio show that he’s completed nine rounds of chemotherapy and seven weeks of radiation treatments after being diagnosed with oral cancer this past summer and that he’ll find out in February if the treatments were successful. […]

Continue reading...